Summary: SNMMI/ACNM Procedure Standard for Posttreatment Imaging of <sup>177</sup>Lu-Based Radiopharmaceuticals
C. Uribe, Amir Iravani, Bital Savir-Baruch, Heather A. Jacene, Stephen A. Graves, Yuni K. Dewaraja, Courtney Lawhn-Heath, Thomas A. Hope
Abstract
Radiopharmaceutical therapies (RPTs) use radiolabeled molecules to target biomarkers preferentially expressed on tumor cell surfaces. Prior to therapy, PET is used to assess whether the radiopharmaceutical demonstrates sufficient tumor localization. If present, the cells can be targeted with the
Topics & Concepts
MedicineNuclear medicineTumor cellsMolecular imagingMedical imagingPositron emission tomographyPet imagingRadioimmunotherapyCancer researchRadiation therapyCancerRadiopharmaceutical Chemistry and ApplicationsMedical Imaging Techniques and ApplicationsNeuroendocrine Tumor Research Advances